BIOPHARMA CREDIT
BioPharma Credit provides investors with an opportunity to gain exposure to the fast growing life sciences industry.
BIOPHARMA CREDIT
Industry:
Finance
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Stock Details
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-05-28 | BioDelivery Sciences | BioPharma Credit investment in Post-IPO Debt - BioDelivery Sciences | 60 M USD |
| 2018-02-07 | NovoCure | BioPharma Credit investment in Post-IPO Debt - NovoCure | 150 M USD |
More informations about "BioPharma Credit"
About BioPharma Credit PLC
BioPharma Credit will target an annual dividend yield of 7 per cent. (calculated by reference to the Issue Price), and a net total return on NAV of 8 to 9 per cent. per annum in the medium term. …See details»
BioPharma Credit Investor Materials - bpcruk.com
Mar 5, 2025 Browse Our Library of Investor Materials from BioPharma Credit. Category: Year: Search: Investor Update – February 2025. Fact Sheets. View Upload. Investor Presentation – …See details»
BioPharma Credit - Crunchbase Investor Profile
BioPharma Credit provides investors with an opportunity to gain exposure to the fast growing life sciences industry. Lists Featuring This Company. Edit Lists …See details»
BioPharma Credit PLC - London Stock Exchange
4 days ago BioPharma Credit PLC instruments. Select instrument to view. Search by instrument name, code, ISIN or SEDOL. Equity (2) Code Instrument name Price Change Type …See details»
BioPharma Credit (LON:BPCR) Company Profile & Description
2 days ago BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of …See details»
BioPharma Credit PLC, BPCP:LSE summary - FT.com - Financial Times
Mar 21, 2025 BioPharma Credit PLC is a United Kingdom-based specialist debt investor to the life sciences industry. The Company seeks to provide long-term shareholder returns, …See details»
BioPharma Credit Ord (BPCR) Quote - Morningstar
Feb 28, 2025 Learn more about the BioPharma Credit Ord (BPCR: xlon) fund quote with Morningstar rating and analysis including NAV, star rating, asset allocation, capital gains, and …See details»
BioPharma Credit PLC (BOPCF) - Yahoo Finance
Find the latest BioPharma Credit PLC (BOPCF) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
BioPharma Credit PLC (BOPCF)
See the company profile for BioPharma Credit PLC (BOPCF) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
BOPCF BioPharma Credit PLC - Seeking Alpha
Dec 10, 2024 A high-level overview of BioPharma Credit PLC (BOPCF) stock. View (BOPCF) real-time stock price, chart, news, analysis, analyst reviews and more.See details»
BioPharma Credit PLC - London Stock Exchange
Mar 21, 2025 BioPharma Credit (BPCR) delivered a 7.3% NAV total return (NAV TR) pa in the three-year period endin... View report. 1 April 2021. BioPharma Credit - Debt investment in a …See details»
factsheet - BioPharma Credit
This website is not intended to offer or to promote the offer or sale of the shares (the “shares”) of biopharma credit plc (the “company”) in the united states or to any “u.s. persons” as defined in …See details»
BIOPHARMA CREDIT PLC - Companies House
Registers for BIOPHARMA CREDIT PLC (10443190) More for BIOPHARMA CREDIT PLC (10443190) Registered office address Central Square, 29 Wellington Street, Leeds, United …See details»
BioPharma Credit PLC, BPCR:LSE profile - FT.com - Financial Times
Year on year BioPharma Credit PLC 's revenues fell -37.78% from 218.14m to 135.73m. This along with an increase in the cost of goods sold expense has contributed to a reduction in net …See details»
BioPharma Credit (LON:BPCP) Stock Price & Overview - Stock …
3 days ago BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of …See details»
Biopharma Credit Plc Ord USD0.01 Fund factsheet - Trustnet
Jan 6, 2025 The latest fund information for Biopharma Credit Plc Ord USD0.01, including fund prices, fund performance, ratings, analysis, asset allocation, ratios & fund manager information.See details»
BioPharma Credit PLC, BPCR:LSE summary - FT.com - Financial Times
1 day ago As of last trade BioPharma Credit PLC (BPCR:LSE) traded at 0.884, 6.51% above its 52-week low of 0.83, set on Feb 03, 2025.See details»
BioPharma Credit Plc BPCR - DividendMax
The next BioPharma Credit Plc dividend will go ex in 9 days for 1.75c and will be paid in 1 month. The previous BioPharma Credit Plc dividend was 0.9031p and it went ex 2 months ago and it …See details»
Simplification for success: Rewiring the biopharma operating model
Mar 21, 2025 Pharmaceutical organizations often struggle with time-consuming processes that demand excessive involvement across multiple levels of the company, including financial …See details»
BioPharma Credit PLC (BOPCF) - Yahoo Finance Canada
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved …See details»